Please use this identifier to cite or link to this item:
|Title:||Ratiometric delivery of cisplatin and doxorubicin using tumour-targeting carbon-nanotubes entrapping platinum(iv) prodrugs|
|Source:||Chin, C.F., Yap, S.Q., Li, J., Pastorin, G., Ang, W.H. (2014). Ratiometric delivery of cisplatin and doxorubicin using tumour-targeting carbon-nanotubes entrapping platinum(iv) prodrugs. Chemical Science 5 (6) : 2265-2270. ScholarBank@NUS Repository. https://doi.org/10.1039/c3sc53106f|
|Abstract:||Combination therapy is an effective strategy to enhance the efficacy of single-agent chemotherapy and delay onset of chemoresistance. However, differences in the pharmacokinetic profiles of the drug constituents can complicate the implementation of combination regimens in a clinical setting. Nanomaterials can overcome these limitations by offering a unified platform for targeted and synchronous delivery of multiple drugs, although exact ratiometric loading cannot be assured using conventional encapsulation techniques. An approach was conceived with the goal of delivering exact stoichiometric proportions of cisplatin and doxorubicin against endometrial adenocarcinoma using tumour-targeting multi-walled carbon nanotubes entrapping an inert Pt(iv) prodrug. Activation of the Pt(iv) prodrug after cell entry, synchronously releases molar equivalents of hydrophilic cisplatin and doxorubicin from the hydrophobic confines, thereby achieving ratiometric delivery of these mechanistically-complementary drug entities. This journal is © the Partner Organisations 2014.|
|Source Title:||Chemical Science|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 22, 2018
WEB OF SCIENCETM
checked on Jan 29, 2018
checked on Feb 19, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.